Mitsubishi UFJ Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.1M | Sell |
|
|||||
|
2025
Q1 | $11.7M | Buy |
|
|||||
|
2024
Q4 | $9.57M | Buy |
|
|||||
|
2024
Q3 | $8.9M | Sell |
|
|||||
|
2024
Q2 | $10.4M | Buy |
|
|||||
|
2024
Q1 | $9.32M | Buy |
|
|||||
|
2023
Q4 | $8.08M | Sell |
|
|||||
|
2023
Q3 | $7.42M | Buy |
|
|||||
|
2023
Q2 | $6.69M | Buy |
|
|||||
|
2023
Q1 | $6.44M | Buy |
|
|||||
|
2022
Q4 | $6.21M | Buy |
|
|||||
|
2022
Q3 | $4.9M | Buy |
|
|||||
|
2022
Q2 | $4.43M | Buy |
|
|||||
|
2022
Q1 | $3.83M | Sell |
|
|||||
|
2021
Q4 | $4.49M | Buy |
|
|||||
|
2021
Q3 | $3.36M | Hold |
|
|||||
|
2021
Q2 | $3.63M | Buy |
|
|||||
|
2021
Q1 | $3.11M | Buy |
|
|||||
|
2020
Q4 | $3.28M | Buy |
|
|||||
|
2020
Q3 | $2.81M | Buy |
|
|||||
|
2020
Q2 | $3.81M | Buy |
|
|||||
|
2020
Q1 | $2.42M | Sell |
|
|||||
|
2019
Q4 | $2.5M | Buy |
|
|||||
|
2019
Q3 | $1.76M | Sell |
|
|||||
|
2019
Q2 | $2.46M | Buy |
|
|||||
|
2019
Q1 | $2.29M | Buy |
|
|||||
|
2018
Q4 | $2.09M | Sell |
|
|||||
|
2018
Q3 | $2.59M | Buy |
|
|||||
|
2018
Q2 | $2.31M | Buy |
|
|||||
|
2018
Q1 | $1.94M | Sell |
|
|||||
|
2017
Q4 | $2.7M | Sell |
|
|||||
|
2017
Q3 | $2.85M | Buy |
|
|||||
|
2017
Q2 | $2.34M | Buy |
|
|||||
|
2017
Q1 | $2.24M | Buy |
|
|||||
|
2016
Q4 | $2.16M | Buy |
|
|||||
|
2016
Q3 | $2.16M | Buy |
|
|||||
|
2016
Q2 | $1.77M | Buy |
|
|||||
|
2016
Q1 | $1.82M | Sell |
|
|||||
|
2015
Q4 | $2.52M | Sell |
|
|||||
|
2015
Q3 | $4.69M | Buy |
|
|||||
|
2015
Q2 | $4.72M | Buy |
|
|||||
|
2015
Q1 | $4.12M | Buy |
|
|||||
|
2014
Q4 | $1.81M | Sell |
|
|||||
|
2014
Q3 | $1.6M | Sell |
|
|||||
|
2014
Q2 | $1.45M | Sell |
|
|||||
|
2014
Q1 | $1.7M | Sell |
|
|||||
|
2013
Q4 | $1.79M | Sell |
|
|||||
|
2013
Q3 | $2.05M | Buy |
|
|||||
|
2013
Q2 | $1.53M | Buy |
|